126 related articles for article (PubMed ID: 19127806)
21. Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients.
Ito M; Okubo A; Sonoda Y; Yamakiri K; Sakamoto T
Ophthalmologica; 2006; 220(2):118-24. PubMed ID: 16491035
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of injection frequency and visual acuity outcomes for ranibizumab monotherapy in exudative age-related macular degeneration.
Dadgostar H; Ventura AA; Chung JY; Sharma S; Kaiser PK
Ophthalmology; 2009 Sep; 116(9):1740-7. PubMed ID: 19643484
[TBL] [Abstract][Full Text] [Related]
23. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
[TBL] [Abstract][Full Text] [Related]
24. Long-term effect of intravitreal triamcinolone in the nonproliferative stage of type II idiopathic parafoveal telangiectasia.
Wu L; Evans T; Arévalo JF; Berrocal MH; Rodríguez FJ; Hsu M; Sánchez JG
Retina; 2008 Feb; 28(2):314-9. PubMed ID: 18301037
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal triamcinolone acetonide treatment for serpiginous choroiditis.
Adigüzel U; Sari A; Ozmen C; Oz O
Ocul Immunol Inflamm; 2006 Dec; 14(6):375-8. PubMed ID: 17162609
[TBL] [Abstract][Full Text] [Related]
26. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044
[TBL] [Abstract][Full Text] [Related]
27. Low-power transpupillary thermotherapy combined with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization.
Zhang X; Zhu X; Wang D; Xu L; Jonas JB
Ophthalmic Res; 2007; 39(4):241-2. PubMed ID: 17622745
[TBL] [Abstract][Full Text] [Related]
28. A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy.
Krebs I; Binder S; Stolba U
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):863-7. PubMed ID: 16331486
[TBL] [Abstract][Full Text] [Related]
29. Intravitreal steroids may facilitate treatment of Eales' disease (idiopathic retinal vasculitis): an interventional case series.
Ishaq M; Feroze AH; Shahid M; Baig MA; Ameen SS; Feroze SH; Chishti RA
Eye (Lond); 2007 Nov; 21(11):1403-5. PubMed ID: 16980931
[TBL] [Abstract][Full Text] [Related]
30. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation.
Krieglstein TR; Kampik A; Ulbig M
Br J Ophthalmol; 2006 Nov; 90(11):1357-60. PubMed ID: 16885191
[TBL] [Abstract][Full Text] [Related]
32. Results of one-year's treatment with ranibizumab for exudative age-related macular degeneration in a clinical setting.
Cohen SY; Dubois L; Tadayoni R; Fajnkuchen F; Nghiem-Buffet S; Delahaye-Mazza C; Guiberteau B; Quentel G
Am J Ophthalmol; 2009 Sep; 148(3):409-13. PubMed ID: 19477713
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation.
Montero JA; Ruiz-Moreno JM; Sanabria MR; Fernandez-Munoz M
Br J Ophthalmol; 2009 Feb; 93(2):166-70. PubMed ID: 18971240
[TBL] [Abstract][Full Text] [Related]
34. Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study.
Sacu S; Varga A; Michels S; Weigert G; Polak K; Vécsei-Marlovits PV; Schmidt-Erfurth U
Br J Ophthalmol; 2008 Oct; 92(10):1347-51. PubMed ID: 18586901
[TBL] [Abstract][Full Text] [Related]
35. Combination therapy of PDT and triamcinolone in CNV associated with fundus flavimaculatus.
Braun B; Schneider U; Hasler P; Prünte C
Klin Monbl Augenheilkd; 2007 Apr; 224(4):353-5. PubMed ID: 17458813
[TBL] [Abstract][Full Text] [Related]
36. [Intravitreal application of triamcinolone--our experiences].
Konjević Pernar S; Vatavuk Z; Bencić G; Pentz A; Mandić Z
Acta Med Croatica; 2006; 60(2):133-5. PubMed ID: 16848205
[TBL] [Abstract][Full Text] [Related]
37. Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration.
Jonas JB; Spandau UH; Kamppeter BA; Degenring RF; Kreissig I; Akkoyun I; Vossmerbaeumer U
J Ocul Pharmacol Ther; 2006 Jun; 22(3):194-9. PubMed ID: 16808681
[TBL] [Abstract][Full Text] [Related]
38. Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration.
Jonas JB; Strueven V; Kamppeter BA; Harder B; Spandau UH; Schlichtenbrede F
J Ocul Pharmacol Ther; 2006 Oct; 22(5):370-6. PubMed ID: 17076632
[TBL] [Abstract][Full Text] [Related]
39. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema.
Gillies MC; Simpson JM; Gaston C; Hunt G; Ali H; Zhu M; Sutter F
Ophthalmology; 2009 Nov; 116(11):2182-7. PubMed ID: 19796823
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone improves recovery of visual acuity in nonarteritic anterior ischemic optic neuropathy.
Kaderli B; Avci R; Yucel A; Guler K; Gelisken O
J Neuroophthalmol; 2007 Sep; 27(3):164-8. PubMed ID: 17895814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
